OncoGenex Pharmaceuticals Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BOTHELL, Wash. and VANCOUVER, British Columbia, May 2, 2013 /PRNewswire via COMTEX/ -- OncoGenex Pharmaceuticals, Inc. /quotes/zigman/111981/quotes/nls/ogxi OGXI +1.38% today provided an overview of clinical development activities for its two product candidates, custirsen and OGX-427, and announced first quarter 2013 financial results.
Help employers find you! Check out all the jobs and post your resume.
BOTHELL, Wash. and VANCOUVER, British Columbia, May 2, 2013 /PRNewswire via COMTEX/ -- OncoGenex Pharmaceuticals, Inc. /quotes/zigman/111981/quotes/nls/ogxi OGXI +1.38% today provided an overview of clinical development activities for its two product candidates, custirsen and OGX-427, and announced first quarter 2013 financial results.
Help employers find you! Check out all the jobs and post your resume.